Discovery & preclinical research
Accelerate your discovery by defining disease targets, accurately quantifying unmet patient needs, mapping disease burdens, and clearly establishing preclinical feasibility using verified real-world insights.
Clinical development
(Phases I–III):
Enhance trial outcomes and improve success rates through integrated RWD that drives better feasibility, recruitment and insights derived from advanced cohort discovery, modeling and longitudinal tracking.
Trial site feasibility & selection
Precisely define patient populations and accelerate clinical site selection by rapidly identifying eligible cohorts, optimizing feasibility modeling, and integrating expansive, multimodal real-world datasets.
Regulatory review & approval
Ensure FDA and EMA trial approval and strengthen regulatory filings with regulatory-grade, validated real-world evidence—clearly demonstrating safety, efficacy, clinical outcomes, and economic impact.
Commercialization & market access
Achieve rapid market penetration and optimize prescriber engagement and payer strategy by precisely targeting patients and leveraging comprehensive, real-time insights into patient, prescriber, and payer activity.
Health Economics and Outcomes Research (HEOR)
Demonstrate economic value, comparative effectiveness, and market impact by leveraging comprehensive, real-world evidence from verified patient data and detailed claims insights.
Post-market surveillance (Phase IV) & RWE
Confidently track long-term product safety, efficacy, and economic impact by leveraging verified, linked real-world patient data — capturing comprehensive patient outcomes and insights over time.
Triggers & alerts for patient & prescriber engagement
Capture and swiftly respond to emerging patient and prescriber behavior shifts with timely, actionable insights—enabling brands to proactively monitor prescribing patterns and uncover new treatment opportunities.